Polyurethane films prepared by electrodeposition from polyurethane dispersions

• US 6,514,572 B1
• Filed: 04/13/2000
• Issued: 02/04/2003
• Est. Priority Date: 04/14/1999
• Status: Expired due to Fees

• Current Assignee: Dow Global Technologies, Inc. (Dow, Inc.)
• Original Assignee: Dow Global Technologies, Inc. (Dow, Inc.)
• Inventors: Bhattacharjee, Debkumar, Koonce, William A., McIntyre, James A., Gribble, Michael Y.
• Primary Examiner(s): NILAND, PATRICK DENNIS
• Application Number:
  US09/548,915
• Time in Patent Office: 1,027 Days
• Field of Search: 427/372.2, 427/385.5, 427/458
• US Class Current: 427/458
• CPC Class Codes: C08G 18/12 using two or more compounds having active hydrogen in the first polymerisation step
• CPC Class Codes: C08G 18/302 Water
• CPC Class Codes: C08G 18/4808 Mixtures of two or more polyetherdiols
• CPC Class Codes: C08G 18/4841 containing oxyethylene end groups
• CPC Class Codes: C08G 18/50 having heteroatoms other than oxygen
• CPC Class Codes: C09D 5/4465 Polyurethanes

Abstract

A process for preparing polyurethane films is disclosed, comprising electrodepositing the film onto a substrate from a polyurethane dispersion. One advantage of the electrodeposition process of the present invention is that there is no need for an additional step to remove coagulants from the films, as with conventional coagulation processes. Another advantage is that in using electrodeposition, the amount of water that must be removed during a dewatering step is minimized. A third advantage is that the resulting film demonstrates much greater uniformity in thickness as compare to films prepared by conventional coagulation techniques. The present invention has applicability in, for example, medical applications.

Claims

1. A process for preparing a polyurethane film comprising:

electrodepositing the film onto a substrate from a polyurethane dispersion; and

removing the film from the substrate.

2. The process of claim 1 wherein the electrodepositing further comprises

applying a voltage of at least 0.5V to the substrate, relative to a Ag/AgCl reference electrode; and

allowing the polyurethane dispersion to deposit onto the substrate.

3. The process of claim 1, wherein the dispersion is formed in a two or more step process wherein,

(1) in a first step a nonionic prepolymer is formed and, in a subsequent step,

(2) an aqueous dispersion of the prepolymer is formed, in the presence of an anionic surfactant, both steps occurring in the substantial absence of an organic solvent.

4. The process of claim 3 wherein the prepolymer is prepared from a polyurethane prepolymer formulation including a diisocyanate and an active hydrogen containing material.

5. The process of claim 4 wherein the diisocyanate is either:

(a) an aliphatic diisocyanate;

or

(b) an aromatic diisocyanate selected from the group consisting of MDI, TDI, and mixtures thereof; and

wherein the active hydrogen containing material is either;

(a) a mixture of a high molecular weight diol and a low molecular weight diol;

or

(b) a high molecular weight diol, wherein when the active hydrogen containing material does not include a low molecular weight diol, the prepolymer is dispersed in water which includes a difunctional amine chain extender.

6. The process according to claim 1 wherein the dispersion has a particle size of from 0.9 microns to 0.05 microns.

7. The process according to claim 1 wherein the dispersion has a solids content of from 5 to 60 weight percent.

8. A process for preparing a polyurethane film shaped for use in a medical application, said process comprising:

(A) exposing a substrate having a shape suitable for making a film for a medical application to a polyurethane dispersion, said dispersion comprising a nonionic polyurethane prepolymer and an anionic surfactant and being substantially free of organic solvent;

(B) electrodepositing said dispersion onto said substrate to form a film on said substrate; and

(C) removing said film from said substrate to form a film shaped for said medical application.

9. The process of claim 8, wherein said polyurethane film shaped for use in a medical application is a glove, a condom, a medical bag, an angioplasty balloon, or a catheter.

10. The process of claim 8, wherein said polyurethane film shaped for use in a medical application is a glove and said substrate is glove shaped.

11. The process of claim 8, wherein said electrodepositing comprises:

applying a voltage of at least 0.5V to the substrate, relative to a Ag/AgCl reference electrode; and

allowing said polyurethane dispersion to deposit onto said substrate.